What is the Buying Price of Aurobindo Pharma Share?

The Buying Price of Aurobindo Pharma share is 1530.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Aurobindo Pharma Share at Choice?

To buy Aurobindo Pharma stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aurobindo Pharma, choose your preferred order type, and place the trade.

What is the PE ratio of Aurobindo Pharma Shares?

The Price-to-earnings (P/E) ratio of Aurobindo Pharma shares is 25.21. You can compare it with the sector average for relative valuation.

What is the PB ratio of Aurobindo Pharma Shares?

The Price to Book (P/B) ratio Aurobindo Pharma shares is 2.33. Useful to assess the stock's value relative to its book value.

Is Aurobindo Pharma Overvalued?

To assess Aurobindo Pharma’s valuation compare Sector P/E, P/B which are 70.34 & 3.13 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Aurobindo Pharma?

The Market Cap of Aurobindo Pharma is 88897.50 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Aurobindo Pharma Share Price?

The 52 week high and low prices of Aurobindo Pharma share price is 1550.9 & 1016.1. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Aurobindo Pharma belong to?

Aurobindo Pharma belongs to the Healthcare sector.

Aurobindo Pharma Share price

AUROPHARMA

Healthcare Large Cap

1530.6

3.60 (-0.23%)

NSE

BSE

Last updated on 24 Jun, 2026 | 15:59 IST

BuySell

Today's High

1550.90

Today's Low

1525.20

52 Week Low

1016.10

52 Week High

1550.90

Aurobindo Pharma Chart

ChartIQ

TradingView

Aurobindo Pharma Share Key Metrics

Volume

10.86 L

Market Cap

88897.50 CR

LTQ@LTP

10@1530.60

ATP

1538.64

Var Margin

14.58 %

Circuit Range

1380.8-1687.6

Delivery %

35.53 %

Value

167.09 CR

ASM/GSM

No

Market Lot

1

Summary

24 Jun, 2026 | 15:59 को, Aurobindo Pharma का शेयर प्राइस आज ₹1530.6 पर है, जो दिन के लिए 3.60% की -0.23 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1525.20 और ₹1550.90 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1016.10 से ₹1550.90 तक रही है। ट्रेडिंग गतिविधि के मामले में, Aurobindo Pharma ने 1085955 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹580801623 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹153864 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 10,153060 रही। यह स्टॉक ₹1380.8-1687.6 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹167.09 CR है। दिन के लिए डिलीवरी परसेंटेज 35.53% रही। इसके अतिरिक्त, Aurobindo Pharma वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Aurobindo Pharma Fundamentals

P/E Ratio

25.21

P/B Ratio

2.33

Div. Yield

0.26

Sector P/E

70.34

Sector P/B

3.13

Sec. Div. Yield

0.53

Aurobindo Pharma Resistance and Support

Pivot 1523.03

Resistance

First Resistance

1553.86

Second Resistance

1573.53

Third Resistance

1604.36

Support

First Support

1503.36

Second Support

1472.53

Third Support

1452.86

Aurobindo Pharma Futures & Options

Aurobindo Pharma Ltd Share Price

1530.6

-3.6 (-0.23%)

Aurobindo Pharma Option Chain

View Price, OI, Greeks & More...

View All

30JUN26

1539.90

1.30 (0.08%)

28JUL26

1547.00

1.20 (0.08%)

25AUG26

1548.00

-3.70 (0.24%)

AUROPHARMA|30JUN26 CE 1520.00

28.35 -2.8 (-8.99%)

AUROPHARMA|30JUN26 PE 1540.00

19.85 -3.45 (-14.81%)

Aurobindo Pharma Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

51.82%

Mutual Fund

17.79%

Insurance

5%

Foreign Institutional Investors

15.24%

Domestic Institutional Investors

3.08%

Retail

7.08%

Others

-0.01%

Total Promoters

MAR '26

51.82%

Aurobindo Pharma Corporate Actions

Date	Agenda
2026-05-21	Audited Results
2026-04-06	Buy Back of Shares
2026-02-09	Quarterly Results

Aurobindo Pharma News

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aurobindo Pharma USA, a subsidiary, received FTC approval to acquire Lannett Company LLC for $250 million. This acquisition will enhance its generic product offerings and add a US-based manufacturing facility, strengthening domestic production capacity.

Jun 22 2026 07:27:51

Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Pre-Approval Inspection (PAI) At Eugia Steriles Private Limited, A 100% Stepdown Subsidiary Of The Company

Aurobindo Pharma's 100% stepdown subsidiary, Eugia Steriles Private Limited, underwent a US FDA Pre-Approval Inspection (PAI) that concluded with 5 observations. The company will address these observations within the stipulated timeframe.

Jun 19 2026 21:10:08

Aurobindo Pharma Ltd - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Aurobindo Pharma USA Inc. obtained the necessary approval from the US Federal Trade Commission (FTC) for its 100% acquisition of Lannett Company LLC from LANNETT SELLER HOLDCO, INC. The transaction is expected to close before the end of this month.

Jun 19 2026 08:24:32

Aurobindo Pharma Ltd - 524804 - Classification Of US FDA Inspection At Unit-III Of Eugia Pharma Specialities Limited, Pashamylaram (Our Wholly Owned Subsidiary) As OAI

Aurobindo Pharma's wholly owned subsidiary, Eugia Pharma Specialities, received an Official Action Indicated (OAI) classification from the US FDA for its Unit-III formulation manufacturing facility. The inspection, conducted from January 27 to February 06, 2026, concluded with 11 observations.

Jun 12 2026 18:17:06

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aurobindo Pharma received final US FDA approval to manufacture and market Tofacitinib Tablets, 5 mg and 10 mg. This allows immediate launch of the product in the US market, which has an estimated market size of US$494 million.

Jun 04 2026 18:16:02

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aurobindo Pharma inaugurated TheraNym, a large-scale biologics contract manufacturing facility in Borapatla, Hyderabad. This marks the company's strategic entry into the high-growth biologics CMO segment, with global pharma giant MSD as an anchor customer.

Jun 03 2026 17:38:00

Name	Position
Mangalam Ramasubramanian Kumar	Chairman
K Nityananda Reddy	Vice Chairman & Managing Director

Aurobindo Pharma Similar Stocks

Dr. Reddy's Laboratories Ltd.

1328.40

27.10 (2.08%)

Lupin Ltd.

2367.60

9.80 (0.42%)

Max Healthcare Institute Ltd.

1081.70

3.65 (0.34%)

Mankind Pharma Ltd.

2483.00

-45.60 (1.80%)

Lenskart Solutions Ltd.

516.35

2.65 (0.52%)

Laurus Labs Ltd.

1454.20

-26.80 (1.81%)

Fortis Healthcare Ltd.

975.40

3.30 (0.34%)

Biocon Ltd.

420.65

-2.55 (0.60%)

Alkem Laboratories Ltd.

5428.50

13.00 (0.24%)

Aurobindo Pharma FAQs

Aurobindo Pharma शेयर का खरीद मूल्य 1530.6 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Aurobindo Pharma शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Aurobindo Pharma शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 25.21 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Aurobindo Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.33 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aurobindo Pharma शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.13 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Aurobindo Pharma का मार्केट कैप 88897.50 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Aurobindo Pharma शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1550.90 और 1016.10 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।